INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023

PLYMOUTH MEETING, Pa., Oct. 26, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that third quarter 2023 financial results will be released after the market close on November 9, 2023. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

A live and archived version of the audio presentation will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts.

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts

Media: Jennie Willson [phone] [e-mail]
Investors: Thomas Hong [phone] [e-mail]

View original content:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2023-financial-results-on-november-9-2023-301968083.html

SOURCE INOVIO Pharmaceuticals, Inc.

Copyright 2023 PR Newswire